Allison Marie Winter, Michael Scordo, Caroline Houillier, Gerald Illerhaus, Alberto Vasconcelos, Joe DeStefano, David Bernasconi, Zhi Cheng, Vincent Bize, Roch Houot. "Lisocabtagene maraleucel (liso-cel) as first-line (1L) therapy for transplant-ineligible patients (pt) with primary central nervous system lymphoma (PCNSL): The CAROLYN study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps7097